Möchten Sie immer auf dem neuesten Stand bleiben?
Erstellen Sie noch heute ein Leserkonto, um die Branchen und Unternehmen zu verfolgen, die Sie interessieren, und passen Sie Ihr Nachrichten-Dashboard an.
-
TORONTO, March 19, 2019 (GLOBE NEWSWIRE) -- Eve & Co Incorporated (“Eve & Co” or the “Company”) (TSX-V: EVE; OTCQB: EEVVF) is pleased to announce that Eve & Co, through its wholly-owned...
-
ATLANTA, March 18, 2019 (GLOBE NEWSWIRE) -- HD Supply Holdings, Inc. (NASDAQ: HDS), one of the largest industrial distributors in North America, today reported Net sales of $6.0 billion in fiscal...
-
shRNA platform complements Company’s all-in-one-vector approach in the design, discovery and development of next-generation CAR-T candidatesAllogeneic T-cells derived by shRNA targeting show...
-
ATLANTA, Ga., March 15, 2019 (GLOBE NEWSWIRE) -- Everywhere Agency, the leading influencer marketing agency, announced today that its CEO, Danica Kombol, has been named Marketer of the Year by the...
-
MEMPHIS, Tenn., March 15, 2019 (GLOBE NEWSWIRE) -- Evergreen Packaging®, a global leader in fiber-based packaging solutions, today released a white paper, “Trend Watchers Say the Topic of the Year...
-
NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES OR DISSEMINATION IN THE UNITED STATES VANCOUVER, British Columbia, March 12, 2019 (GLOBE NEWSWIRE) -- Evermount Ventures Inc. (the “Company”) (TSXV...
-
Fourth quarter Revenues increased 13.8% to $119.5 millionFourth quarter Net income improved to $4.2 million from a loss of $25.0 million and Diluted Earnings per Share improved to $0.06 from a loss of...
-
MONT-SAINT-GUIBERT, Belgium, March 11, 2019 (GLOBE NEWSWIRE) -- Celyad (Euronext Brussels and Paris, and Nasdaq: CYAD), a clinical-stage biopharmaceutical company focused on the development of CAR-T...
-
CAMBRIDGE, Mass., March 08, 2019 (GLOBE NEWSWIRE) -- EverQuote, Inc. (Nasdaq: EVER), a leading online insurance marketplace in the U.S., connecting consumers with insurance providers, today...
-
MONT-SAINT-GUIBERT, Belgium, March 08, 2019 (GLOBE NEWSWIRE) -- Celyad (Euronext Brussels and Paris, and Nasdaq: CYAD), a clinical-stage biopharmaceutical company focused on the development of CAR-T...